Variant · Snv
LAMA2 NM_000426.4(LAMA2):c.9212-15C>A
CI-VAR-00047233Explore in graph →NM_000426.4:c.9212-15C>AClinVar 256095 rs55776770
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 256095 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Congenital muscular dystrophy due to partial LAMA2 deficiency; LAMA2-related muscular dystrophy; Uterine corpus endometrial carcinoma; Pancreatic adenocarcinoma; Familial pancreatic carcinoma; Sarcoma; Gastric cancer; Thymoma; Acute myeloid leukemia; Malignant tumor of esophagus; Nonpapillary renal cell carcinoma; Ovarian cancer; Uterine carcinosarcoma; Cholangiocarcinoma | germline | 9 | Feb 04, 2026 | clinvar |